Continue the search for the ideal nonautogenous arterial conduit while we still can

In the current issue of the Journal of Vascular Surgery, we learn of the latest development in arterial conduits in patients without adequate autogenous tissue for revascularization.1 In their article outlining their phase II trial of the human acellular vessel (HAV), Gutowski and his long list of coauthors with senior author Lawson describe their first-in-man experience with this “novel regenerative surgical therapy.”
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: Invited commentary Source Type: research